Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Hedge fund:659’

Alex Denner Sarissa Capital

Sarissa Capital Management Hires New President

Sarissa Capital Management was one of those rare activist hedge funds, which managed to beat the last year’s tough market environment, returning 15.......(read more)
Insider Trading, NYSE, Markets, Stock Trader On The Phone

Hedge Fund and Insider Trading News: Third Point, Sarissa Capital, Citadel LLC, Point72 Asset Management, Kinder Morgan Inc (KMI), Cyclerion Therapeutics Inc (CYCN), and More

MOVES-Activist Hedge Fund Sarissa Hires President in Push for Growth (Reuters) BOSTON, April 4 (Reuters) – Sarissa Capital Management LP, the activist......(read more)
Alex Denner Sarissa Capital

Sarissa Capital’s Alex Denner Bullish on Biogen (BIIB)

Sarissa Capital Management is a Greenwich, Connecticut-based activist hedge fund established in 2012 by its current chief investment officer, Dr. Alexander......(read more)
Countries with the Smallest Government Per Capita in the World

Hedge Fund and Insider Trading News: Alex Denner, Och-Ziff Capital Management, Point72 Asset Management, United Cannabis Corp (CNAB), Cypress Semiconductor Corporation (CY), and More

Ironwood Pharma May Satisfy Activist Denner with Split-up Plan, but He Still Seeks Board Seat (CNBC) Ironwood Pharmaceuticals’ stock rose Tuesday......(read more)
Insider Trading Back

Hedge Fund and Insider Trading News: Brevan Howard Asset Management, Joseph Edelman, Workday, Inc. (WDAY), Goodrich Petroleum Co. (GDP), Evans & Sutherland (ESCC), and More

Brevan Howard Plans Asia Macro Fund Run by Trader Bathwal (Bloomberg) Brevan Howard Asset Management is raising money for a new macro hedge fund managed......(read more)
Pressmaster/Shutterstock.com

13D Filing: Sarissa Capital Management and Emmaus Life Sciences Inc.

Emmaus Life Sciences Inc.: Alex Denner’s Sarissa Capital Management filed an amended 13D. You can check out Sarissa Capital Management’s latest......(read more)
Pressmaster/Shutterstock.com

13D Filing: Sarissa Capital Management and Apricus Biosciences Inc. (APRI)

Apricus Biosciences Inc. (NASDAQ:APRI): Alex Denner’s Sarissa Capital Management filed an amended 13D. You can check out Sarissa Capital Management......(read more)
Medical treatments, advanced medical equipment, medical devices

13D Filing: Sarissa Capital Management and Novelion Therapeutics Inc. (NVLN)

Novelion Therapeutics Inc. (NASDAQ:NVLN): Alex Denner’s Sarissa Capital Management filed an amended 13D. You can check out Sarissa Capital Management......(read more)
background, modern, room,

Hedge Fund and Insider Trading News: Steven Cohen, Starboard Value, Zendesk Inc (ZEN), CTI BioPharma Corp (CTIC), and More

Steven Cohen’s Hedge Fund ‘Emphatically Denies’ Sex Discrimination Claims in Employee Lawsuit (Fortune) Just as billionaire Steven Cohen......(read more)
Pressmaster/Shutterstock.com

13D Filing: Sarissa Capital Management and Apricus Biosciences Inc. (APRI)

Apricus Biosciences Inc. (NASDAQ:APRI): Alex Denner’s Sarissa Capital Management filed an amended 13D. You can check out Sarissa Capital Management......(read more)
Doctor Specialties with Best Lifestyle

13D Filing: Sarissa Capital Management and Novelion Therapeutics Inc. (NVLN)

You can access the original SEC filing by clicking here. Page 1 of 3 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington, D.......(read more)
Alex Denner Sarissa Capital

13D Filing: Sarissa Capital Management and Novelion Therapeutics Inc. (NVLN)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 7 – SEC Filing CUSIP No.  67001K202 Page 1 of  7 Pages......(read more)
TRIAN PARTNERS

Hedge Fund News: Nelson Peltz, Bill Ackman, Ray Dalio

Peltz May Aim For Seat At GE (TheStreet) Peltz is that rare breed of insurgent known as “operational activists” because his track record as......(read more)
Can hedge funds beat the market

140 Biggest and Most Famous Activist Hedge Funds

Some of the names we are going to show on this top 140 biggest and most famous activist hedge funds list are the investors that keep certain executives......(read more)
Alex Denner Sarissa Capital

Sarissa Capital Management and Aegerion Pharmaceuticals, Inc. (AEGR) Amend Nomination Agreement

In a recent filing with the US Securities and Exchange Commission, Alex Denner‘s Sarissa Capital Management has reported entering into an amendment......(read more)
Jeff Ubben VALUEACT CAPITAL

Ubben Sells More Shares of Motorola Solutions Inc. (MSI), Meister Cuts Stake in This REIT, Plus 2 Other Moves

Fresh data shows that 2015 was the year with the highest number of hedge fund closures since the financial crisis, as increased volatility in equity markets......(read more)
Alex Denner Sarissa Capital

Aegerion Pharmaceuticals, Inc. (AEGR): Sarissa Capital Management Files Amended 13D

Sarissa Capital Management filed an amended 13D today regarding Aegerion Pharmaceuticals (NASDAQ:AEGR) disclosing the confidentiality agreement between......(read more)
Alex Denner Sarissa Capital

One Fund is Buying This Biotech Stock Although It’s Losing Smart Money’s Support

Alex Denner is still bullish on Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) and has further increased his stake in the company. As reported in a recent......(read more)
Alex Denner Sarissa Capital

Hedge Fund News: Alex Denner, Steven Tananbaum, Bill Ackman

Ariad Pharma CEO ‘Retires’ in Settlement With Activist Hedge Fund (The Street) Ariad Pharmaceuticals founder and CEO Harvey Berger is exiting......(read more)
Alex Denner Sarissa Capital

Ariad Pharmaceuticals, Inc. (ARIA), Amgen, Inc. (AMGN): How Sarissa Capital’s Top Picks Beat the Market

Headquartered in Connecticut, Sarissa Capital Management was founded by Alexander J. Denner in 2012. Prior to this, Mr. Denner worked as a portfolio manager......(read more)
Glenn Krevlin

Aegerion Pharmaceuticals, Inc. (AEGR), Joint Corp (JYNT), Trillium Therapeutics Inc. (TRIL): Latest Fund Moves in the Hot Healthcare Sector

At Insider Monkey, we track over 700 of the top hedge funds in the world, following and reporting on their latest moves disclosed through filings with......(read more)
Alex Denner Sarissa Capital

Ariad Pharmaceuticals, Inc., Quest Diagnostics Inc, Amgen, Inc.: Sarissa Capital’s Top Stock Picks and New Moves

Alex Denner’s Sarissa Capital Management recently disclosed its stock picks for the fourth quarter of 2014 in a 13F Form filed with the U.S. Securities......(read more)
Alex Denner Sarissa Capital

Townsquare Media Inc, Aegerion Pharmaceuticals, Inc.: Tricadia Capital Increases Stake; Sarissa Capital Enters New Position

Michael Barnes And Arif Inayatullah’s Tricadia Capital Management recently disclosed an increase to its position in Townsquare Media Inc (NYSE:TSQ)......(read more)
Alex Denner Sarissa Capital

Ariad Pharmaceuticals, Inc. (ARIA): Healthcare-focused Sarissa Capital Inches Up Its Stake to 6.87%

As a new filing with the Securities and Exchange Commission showed, Sarissa Capital Management, a fund led by Alex Denner, has picked up its position......(read more)
Alex Denner Sarissa Capital

Activist Alex Denner’s Sarissa Capital Bets on Ariad Pharmaceuticals Inc (ARIA), Quest Diagnostics Inc (DGX) & Others

Alex Denner’s Sarissa Capital disclosed its holdings in its latest and first 13F filings. The hedge fund has invested $267.02 million in equity portfolio......(read more)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Former Icahn MD’s Sarissa Capital Discloses 6.2% of Ariad Pharmaceuticals

According to a new filing with the SEC, Sarissa Capital Management now holds around 11.5 million shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA),......(read more)